News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
201 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17723)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (245)
2 (268)
3 (95)
4 (1)
5 (6)
6 (48)
7 (300)
8 (281)
9 (312)
10 (112)
11 (2)
12 (8)
13 (250)
14 (196)
15 (213)
16 (211)
17 (121)
18 (12)
19 (15)
20 (224)
21 (214)
22 (226)
23 (201)
24 (85)
25 (3)
26 (7)
27 (215)
28 (222)
29 (206)
30 (220)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Genetown
Garuda Therapeutics Launches with $72 Million Series A Financing
Garuda Therapeutics launched today with an oversubscribed $72 million Series A financing led by Aisling Capital, Northpond Ventures and Orbimed, supported by Cormorant Asset Management
September 23, 2021
·
4 min read
Drug Development
Innovation Pharmaceuticals Provides Update on COVID-19 Clinical Trial, Compassionate Use Requests and Research into Brilacidin’s Broad-Spectrum Antiviral Properties
Innovation Pharmaceuticals today provided an update on the status of its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients
September 23, 2021
·
6 min read
Business
Opentrons Announces $200 Million Series C Round Led by SoftBank Vision Fund 2
Today Opentrons Labworks Inc. has announced SoftBank Vision Fund 2* has led the company’s $200 million Series C investment with participation by Khosla Ventures.
September 23, 2021
·
5 min read
Dental Surgery Instrument Kit Market to Witness Robust Expansion Throughout the Forecast Period 2021-2031
Dental instrument kits are used by dental professionals to provide dental treatment. These kits are designed to be used for examining, manipulating, treating, restoring, and removing teeth and surrounding oral structures.
September 23, 2021
·
5 min read
Laboratory Information Systems Market is estimated to Observe Considerable Growth to 2030 | TMR Research Study
The rising popularity of these systems can be attributed on the back of factors such as enhanced turnaround time, reduced specimen handling time, and increased productivity.
September 23, 2021
·
4 min read
Micro Syringe Pump Market Demand, Insights and Forecast up to 2031
A syringe pump is used to deliver precise amount of liquid sample in highly sensitive research and industrial environments.
September 23, 2021
·
4 min read
Viral Vaccines Market Size Estimated to Observe Significant Growth by 2031
Vaccines are biological preparations, generally produced from living organisms, which enhance immunity against a particular disease.
September 23, 2021
·
5 min read
Pixium Vision announces implantation of first patient in Germany in Prima System European pivotal trial PRIMAvera
Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces the successful first implantation of a patient in Germany in the PRIMAvera pivotal trial.
September 23, 2021
·
3 min read
Drug Development
BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis
BELLUS Health Inc. today announced that the Company has completed patient enrollment in the Phase 2b SOOTHE clinical trial of BLU-5937 in refractory chronic cough
September 23, 2021
·
8 min read
FDA
FDA Grants Humanitarian Use Device Designation to Bionaut Labs for Treatment of Dandy Walker Syndrome
Bionaut Labs today announced that the U.S. Food and Drug Administration (FDA) has granted the Company humanitarian use device (HUD) designation for BNL-201 for the local treatment of Dandy Walker Syndrome, a rare pediatric neurological disorder.
September 23, 2021
·
5 min read
Previous
8 of 21
Next